Bruck Kifle

Array ( [id] => 7190591 [patent_doc_number] => 20040204416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Pharmaceutical composition for the treatment of CNS and other disorders' [patent_app_type] => new [patent_app_number] => 10/833714 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18931 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204416.pdf [firstpage_image] =>[orig_patent_app_number] => 10833714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314867 [patent_doc_number] => 07524837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Benzotriazapinone salts and methods for using same' [patent_app_type] => utility [patent_app_number] => 10/833232 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61581 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524837.pdf [firstpage_image] =>[orig_patent_app_number] => 10833232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378313 [patent_doc_number] => 20040220179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Substituted 1,4-diazepines and uses thereof' [patent_app_type] => new [patent_app_number] => 10/829040 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39903 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220179.pdf [firstpage_image] =>[orig_patent_app_number] => 10829040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 446396 [patent_doc_number] => 07253159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Methods and compositions for immunomodulation using CD1 antigens' [patent_app_type] => utility [patent_app_number] => 10/827616 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18276 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/253/07253159.pdf [firstpage_image] =>[orig_patent_app_number] => 10827616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906261 [patent_doc_number] => 20050101656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => '11-O-METHYLGELDANAMYCIN COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 10/826445 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7236 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101656.pdf [firstpage_image] =>[orig_patent_app_number] => 10826445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056481 [patent_doc_number] => 06855705 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => '11-O-methylgeldanamycin compounds' [patent_app_type] => utility [patent_app_number] => 10/825788 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7241 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855705.pdf [firstpage_image] =>[orig_patent_app_number] => 10825788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433939 [patent_doc_number] => 20040266668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/826743 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32733 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266668.pdf [firstpage_image] =>[orig_patent_app_number] => 10826743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034652 [patent_doc_number] => 06875863 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-05 [patent_title] => '11-O-methylgeldanamycin compounds' [patent_app_type] => utility [patent_app_number] => 10/826447 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7255 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875863.pdf [firstpage_image] =>[orig_patent_app_number] => 10826447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040751 [patent_doc_number] => 06870049 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => '11-O-methylgeldanamycin compounds' [patent_app_type] => utility [patent_app_number] => 10/826446 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7242 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/870/06870049.pdf [firstpage_image] =>[orig_patent_app_number] => 10826446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237191 [patent_doc_number] => 20070129348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/553273 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 67483 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129348.pdf [firstpage_image] =>[orig_patent_app_number] => 10553273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728701 [patent_doc_number] => 07041662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Substituted benzo [b] azepin-2-one compounds' [patent_app_type] => utility [patent_app_number] => 10/824244 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10062 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041662.pdf [firstpage_image] =>[orig_patent_app_number] => 10824244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194400 [patent_doc_number] => 20070082884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Selective serine/threonine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/552847 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17188 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082884.pdf [firstpage_image] =>[orig_patent_app_number] => 10552847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705735 [patent_doc_number] => 20060194783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Cgrp receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/551830 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21318 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194783.pdf [firstpage_image] =>[orig_patent_app_number] => 10551830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995177 [patent_doc_number] => 20070010522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/552302 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11313 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010522.pdf [firstpage_image] =>[orig_patent_app_number] => 10552302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 518789 [patent_doc_number] => 07189710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'C2-fluoro pyrrolo [2,1−c][1,4]benzodiazepine dimers' [patent_app_type] => utility [patent_app_number] => 10/812840 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4717 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189710.pdf [firstpage_image] =>[orig_patent_app_number] => 10812840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020113 [patent_doc_number] => 20050222132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'C8 - linked pyrrolo[2,1-c][1,4]benzodiazepine-acridone/acridine hybrids' [patent_app_type] => utility [patent_app_number] => 10/812841 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6579 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222132.pdf [firstpage_image] =>[orig_patent_app_number] => 10812841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020114 [patent_doc_number] => 20050222133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'PROCESS FOR PREPARING PYRROLO[2, 1-C] [1,4] BENZODIAZEPINE HYBRIDS' [patent_app_type] => utility [patent_app_number] => 10/812842 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6955 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222133.pdf [firstpage_image] =>[orig_patent_app_number] => 10812842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705738 [patent_doc_number] => 20060194786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Process and intermediates for preparing benzazepines' [patent_app_type] => utility [patent_app_number] => 10/551710 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12045 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194786.pdf [firstpage_image] =>[orig_patent_app_number] => 10551710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760736 [patent_doc_number] => 20060211681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Adenosine deaminase inhibitor and novel bacillus sp. iada-7 strain which produces it' [patent_app_type] => utility [patent_app_number] => 10/550301 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8597 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211681.pdf [firstpage_image] =>[orig_patent_app_number] => 10550301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 500993 [patent_doc_number] => 07205293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Benodiazepine spirohydantoin CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/547228 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12029 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205293.pdf [firstpage_image] =>[orig_patent_app_number] => 10547228 [rel_patent_id] =>[rel_patent_doc_number] =>)